STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
STC-Stem Cell Treatment & Research Institute (STRI) stands out with its breakthrough technology perfecting the pluripotency of stem cells….
460 patents regarding nEPS are registered in 147 countries.
460 Patents Regarding nEPS (newly Elicited Pluripotent Stem Cells without Side Effects by natural compounds) have been registered in 147 different countries.
STRI registered a patent for liver cell differentiation using the world’s first pluripotent stem cells without side effects (nEPS) at EU
STRI registered a patent for liver cell differentiation using the world’s first pluripotent stem cells without side effects (nEPS) at EU
STRI achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects using natural compounds(nEPS)’ at EU
STRI achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects using natural compounds(nEPS)’ at EU
bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
bBHC introduced Cell 97.7 and Celgen branded products at International Beauty Expo 2019
bBHC introduced Cell 97.7 and Celgen branded products at International Beauty Expo 2019